Neuroscience Therapy Corp. has received FDA approval to begin marketing its electronic pain relief device the P-Stim in the United States. P-Stim, which the company claims has been highly successful in treating pain in thousands of patients in Europe, is now permitted to be marketed in the U.S. It is a miniaturized electro-stimulation device that is placed behind the ear with adhesive. It transmits low frequency electrical pulses via acupuncture-like needles inserted into the ear muscles. Medical Technology Business Europe (http://mtbeurope.info/news/2006/605024.htm)
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Indianapolis Firm Called Out for Complaint Investigations
The facility lacked adequate procedures for quality audits, the agency found.
Aquestive Petitions FDA to Halt Approval of NDA for Emergency Seizure Spray
Aquestive submitted a rolling NDA for its own seizure cluster drug in May.
